These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 18827143

  • 1. ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth.
    Society for Maternal Fetal Medicine Publications Committee.
    Obstet Gynecol; 2008 Oct; 112(4):963-5. PubMed ID: 18827143
    [No Abstract] [Full Text] [Related]

  • 2. [Progesterone for prevention of preterm delivery: only in trial setting].
    Lim AC, Mol BW, Bruinse HW.
    Ned Tijdschr Geneeskd; 2010 Oct; 154():A1730. PubMed ID: 20858311
    [Abstract] [Full Text] [Related]

  • 3. [Progesteron--an old--new option in the prevention of preterm birth].
    Rath W.
    Z Geburtshilfe Neonatol; 2008 Aug; 212(4):125-6. PubMed ID: 18729034
    [No Abstract] [Full Text] [Related]

  • 4. Use of progesterone treatment for the prevention of recurrent preterm birth: identification of obstacles to change.
    Lim AC, Goossens A, Ravelli AC, Boer K, Bruinse HW, Mol BW.
    Am J Perinatol; 2010 Mar; 27(3):241-9. PubMed ID: 19823963
    [Abstract] [Full Text] [Related]

  • 5. Progestational agents for the prevention of preterm birth.
    Lamont RF, Jayasooriya GS.
    J Perinat Med; 2009 Mar; 37(1):12-4. PubMed ID: 18999914
    [Abstract] [Full Text] [Related]

  • 6. What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?
    Hall NR.
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):235-46, ix-x. PubMed ID: 21575799
    [Abstract] [Full Text] [Related]

  • 7. Using 17 α-hydroxyprogesterone caproate to impact rates of recurrent preterm delivery in clinical practice.
    Rebarber A, Fox NS, Klauser CK, Istwan NB, Rhea DJ, Stanziano GJ, Saltzman DH.
    J Matern Fetal Neonatal Med; 2010 Oct; 23(10):1139-42. PubMed ID: 20170407
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial of micronized progesterone for the prevention of recurrent preterm birth.
    Glover MM, McKenna DS, Downing CM, Smith DB, Croom CS, Sonek JD.
    Am J Perinatol; 2011 May; 28(5):377-81. PubMed ID: 21380990
    [Abstract] [Full Text] [Related]

  • 9. Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India.
    Majhi P, Bagga R, Kalra J, Sharma M.
    J Obstet Gynaecol; 2009 Aug; 29(6):493-8. PubMed ID: 19697195
    [Abstract] [Full Text] [Related]

  • 10. Deus ex Makena?
    Das AF, Birch R, Meis PJ.
    Obstet Gynecol; 2011 Oct; 118(4):955; author reply 955-6. PubMed ID: 21934462
    [No Abstract] [Full Text] [Related]

  • 11. The safety of progesterone and 17-hydroxyprogesterone caproate administration for the prevention of preterm birth: an evidence-based assessment.
    O'Brien JM.
    Am J Perinatol; 2012 Oct; 29(9):665-72. PubMed ID: 22773279
    [Abstract] [Full Text] [Related]

  • 12. Progestins for the prevention of spontaneous preterm birth: review and implications of recent studies.
    O'Brien JM, Lewis DF.
    J Reprod Med; 2009 Feb; 54(2):73-87. PubMed ID: 19301570
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of progesterone in maternal and fetal medicine.
    Di Renzo GC, Giardina I, Clerici G, Mattei A, Alajmi AH, Gerli S.
    Gynecol Endocrinol; 2012 Nov; 28(11):925-32. PubMed ID: 23057618
    [Abstract] [Full Text] [Related]

  • 16. Progesterone to prevent preterm birth in twin gestations: what is the next step forward?
    Romero R.
    BJOG; 2013 Jan; 120(1):1-4. PubMed ID: 23237263
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Re-analysis of the PREGNANT trial confirms that vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix.
    McKay LA, Holford TR, Bracken MB.
    Ultrasound Obstet Gynecol; 2014 May; 43(5):596-7. PubMed ID: 24585456
    [No Abstract] [Full Text] [Related]

  • 19. Universal cervical-length screening and vaginal progesterone prevents early preterm births, reduces neonatal morbidity and is cost saving: doing nothing is no longer an option.
    Campbell S.
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):1-9. PubMed ID: 21713990
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.